US Patient Monitoring Market

US Patient Monitoring Market Analysis

The US Patient Monitoring Market size is estimated at USD 16.22 billion in 2025, and is expected to reach USD 23.40 billion by 2030, at a CAGR of 7.61% during the forecast period (2025-2030).

• The market is expected to grow with the rising prevalence of chronic diseases due to lifestyle changes and a growing preference for home and remote monitoring.
• The prevalence of chronic diseases is on the rise in the United States, which is expected to create more demand for patient monitoring for the management of diseases. For instance, according to data published by the CRT Group Foundation in August 2022, the number of individuals living with hypertension would increase by 27.2% to 162.5 million from 127.8 million from 2025 to 2060. Further, according to the data published by the United States Census Bureau in November 2022, more than 34 million adults were recorded to live with diabetes in the United States, and it was estimated that 88 million more individuals were at risk of developing the disease. Also, the adoption of remote and home-based patient monitoring has been increasing.
• Moreover, the growing burden of cancer is expected to increase the demand for patient care monitor solutions due to the long-term care required in cancer, contributing to the market growth over the forecast periods. For instance, according to the data updated by the American Cancer Society 2024, 1.96 million new cancer cases are expected to occur in the United States by the end of 2023, which increase to 2 million by 2024. Thus, the high burden of cancer is expected to increase demand for patient monitoring solutions is expected to boost the market growth over the forecast period.
• The market players are engaged in strategic activities such as product launches, mergers, and acquisitions, which are likely to contribute to the growth of the market over the forecast period. For instance, in January 2022, Omron Healthcare launched heart-focused remote patient monitoring. This launch would expand digital health services to consumers and monitor risks of heart disease and other ailments.
• Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the resistance from healthcare industry professionals toward the adoption of patient monitoring systems is likely to impede market growth.

US Patient Monitoring Market Trends

The Hemodynamic Monitoring Devices Segment is Expected to Witness Significant Growth Over the Forecast Period

• Hemodynamic monitoring devices are medical devices that are used to evaluate heart functioning and blood circulation. Hemodynamic monitoring devices are expected to grow further with their increasing adoption and high prevalence of cardiovascular diseases, hypertension, and other chronic diseases.
• Several studies have underlined the benefit of using hemodynamic monitoring devices and their advanced technologies for the management of diseases. For instance, a study published in the Current Opinion in Critical Care by researchers of the University of Pittsburgh in August 2021 underlined the advantage of hemodynamic monitoring for the staging, diagnosis, initial treatment, and management of cardiogenic shock patients.
• Further, a study published in the Journal of Critical Care in September 2022 highlighted effective hemodynamic monitoring for the management of the new onset cardiovascular insufficiency (CVI) in patients of perioperative care. The hemodynamic monitoring included patient-specific personalized resuscitation limiting less fluid administration, reduced length of care, limited vasopressor duration, and others. The study also emphasized process-specific patient monitoring, which is based on the modification of the therapeutic interventions to offer patient-centered outcomes.
• Also, a study published in the Journal of Current Heart Failure Reports by the researchers of Allegheny Health Network in February 2022 mentioned the vast potential of Wireless Hemodynamic Monitoring, which can expand patient coverage for the management of heart failure. The study stated the use of wireless hemodynamic monitoring with a pulmonary artery pressure sensor has offered high safety and efficacy in assessing the change in the intracardiac pressures, which can help predict heart failure events and can offer lead time, which is essential for optimizing the patients.
• The implementation of this device has shown improved outcomes in patients with heart failure regardless of reduced or preserved ejection fraction. Such research studies highlight the efficient monitoring of the patient's heart functioning and blood circulation, along with the other benefits, including expanded monitoring coverage and personalized monitoring, which are expected to increase the demand for hemodynamic monitoring devices in the United States, which is expected to boost the segment's growth.
• Therefore, the hemodynamic monitoring devices segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including its usage for the management of the patient's heart function and blood flow and technological advancements.

The Respiratory Segment is Expected to Witness Significant Growth Over the Forecast Period

• Respiratory monitoring of the patient involves the monitoring of the respiratory rate of breathing, which helps diagnose a medical condition and manage the disease. The significant prevalence of respiratory disorders is expected to create more demand for patient monitoring devices for the management and monitoring of the patient's respiration in the United States. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC) in October 2022, over 15 million people were affected with COPD in the United States.
• Furthermore, a significant advancement for the respiratory monitoring segment is expected to contribute to the segment's growth over the forecast period. For instance, in March 2023 Teva Pharmaceuticals rolled out a respiratory patient monitoring initiative in collaboration with Rimidi, a prominent clinical management platform. This program, leveraging data from Teva’s Digihaler System, is now operational at California’s Desert Oasis Healthcare (DOHC). Teva's Digihaler stands out as the sole smart inhaler system, offering precise data to aid both patients and physicians in optimizing asthma care. This development marks a notable step forward in enhancing respiratory health management, showcasing the potential of integrated digital health solutions in improving patient outcomes.
• Thus, with the wide usage of monitoring the patient's respiration and its high efficacy, the respiratory segment is expected to witness significant growth over the forecast period.

US Patient Monitoring Industry Overview

The United States patient care monitoring equipment market is fragmented in nature due to the presence of several companies operating in the country. The key players operating in the market include Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, General Electric Company (GE Healthcare), and Koninklijke Philips NV.

US Patient Monitoring Market Leaders

US Patient Monitoring Market News

• January 2024: Corsano Health's CardioWatch System, an advanced real-time monitoring system, received FDA clearance. The system includes a bracelet worn by adult patients (at least 22 years old), a web-based browser, and a mobile app that can operate in either patient or healthcare professional (HCP) mode.
• April 2023: Honeywell developed a real-time health monitoring system, which captures and records patients' vital signs in both the hospital setting and remote setting. The system utilizes advanced sensing technology for the monitoring of vital signs through a skin patch, which connects the data instantaneously to healthcare providers on mobile devices and an online dashboard.